[HTML][HTML] Addressing the side effects of contemporary antidepressant drugs: a comprehensive review
SM Wang, C Han, WM Bahk, SJ Lee… - Chonnam medical …, 2018 - ncbi.nlm.nih.gov
Randomized trials have shown that selective serotonin reuptake inhibitors (SSRIs) and
serotonin-norepinephrine reuptake inhibitors (SNRIs) have better safety profiles than …
serotonin-norepinephrine reuptake inhibitors (SNRIs) have better safety profiles than …
The genetic determinants of smoking
V Batra, AA Patkar, WH Berrettini, SP Weinstein… - Chest, 2003 - Elsevier
Dependence on tobacco, like many other drug dependencies, is a complex behavior with
both genetic and environmental factors contributing to the variance. The heritability …
both genetic and environmental factors contributing to the variance. The heritability …
Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants
The brain is an organ predisposed to oxidative/nitrosative stress. This is especially true in
the case of aging as well as several neurodegenerative diseases. Under such …
the case of aging as well as several neurodegenerative diseases. Under such …
Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise
DM Marks, MJ Shah, AA Patkar… - Current …, 2009 - ingentaconnect.com
The precise mechanisms of pain perception and transmission in the central nervous system
have not been fully elucidated. However, extensive data support a role for the monoamine …
have not been fully elucidated. However, extensive data support a role for the monoamine …
Psychometric properties of the Patient Health Questionnaire–15 (PHQ–15) for measuring the somatic symptoms of psychiatric outpatients
Background About 2% to 5% of all primary-care patients have a somatization disorder, and
somatic symptoms are strongly associated with comorbid depression and anxiety disorders …
somatic symptoms are strongly associated with comorbid depression and anxiety disorders …
A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it
LJ Paulozzi, RH Weisler, AA Patkar - Journal of Clinical …, 2011 - psychiatrist.com
Both the usage of prescription drugs such as opioid analgesics and benzodiazepines and
overdoses involving them have increased dramatically in the United States since the 1990s …
overdoses involving them have increased dramatically in the United States since the 1990s …
Relationship between tobacco smoking and positive and negative symptoms in schizophrenia
AA Patkar, R Gopalakrishnan, A Lundy… - The Journal of …, 2002 - journals.lww.com
In an attempt to understand the reasons behind the high prevalence of tobacco smoking in
patients with schizophrenia, the study examined whether specific symptoms of …
patients with schizophrenia, the study examined whether specific symptoms of …
Non-prescribed use of pain relievers among adolescents in the United States
LT Wu, DJ Pilowsky, AA Patkar - Drug and alcohol dependence, 2008 - Elsevier
BACKGROUND: We examined gender-specific prevalences, patterns, and correlates of non-
prescribed use of pain relievers–mainly opioids–in a representative sample of American …
prescribed use of pain relievers–mainly opioids–in a representative sample of American …
Pre—treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African—American cocaine—dependent …
AA Patkar, HW Murray, P Mannelli… - Journal of addictive …, 2004 - Taylor & Francis
We investigated whether measures of impulsivity, aggression and sensation seeking
differed between cocainedependent subjects and controls, and whether these measures …
differed between cocainedependent subjects and controls, and whether these measures …
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant …
We examined the efficacy and tolerability of augmentation with an extended release
formulation of methylphenidate (OROS MPH, Concerta) in patients with major depression …
formulation of methylphenidate (OROS MPH, Concerta) in patients with major depression …